Etiology Study of Prostatitis
Modern Genetic Methods to Test EPS Samples in Prostatitis Patients
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Olga Arsovska
- Phone Number: 62421 6048754111
- Email: olga.arsovska@ubc.ca
Study Contact Backup
- Name: Guangming Yin
- Phone Number: 62421 6048754111
- Email: yingm75@126.com
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z1M9
- Recruiting
- Vancouver General Hospital
-
Sub-Investigator:
- Ryan Paterson, MD
-
Sub-Investigator:
- Elspeth McDougall, MD
-
Contact:
- Olga Arsovska
- Phone Number: 62421 6048754111
-
Sub-Investigator:
- Guangming Yin, MD
-
Sub-Investigator:
- Chris Nguan, MD
-
Sub-Investigator:
- Mark Nigro, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- chronic prostatitis (bacteria or non-bacterial prostatitis) with pelvic pain and LUTS (low urinary tract symptom); diagnosed mainly by NIH-CPSI score. We use NIH-CPSI score 15 as a base line for identifying prostatitis patients:those scored more than 15 will be grouped as prostatitis patients.
Exclusion Criteria:
- Inadequate follow-up data
- Other types of prostatits patients
- Patients who in the opinion of the investigators would not be suitable for study
- UTI patients (within 6 months before enrolment)
- Antibiotics (within 6 months before enrolment)
- Urinary tract surgery (within 6 months before enrolment)
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Prostatitis patients
We will enroll patients from the outpatient clinic who are suffering from pelvic pain (perineal, suprapubic, testicular, penile etc), have urinary symptoms and sexual dysfunction (primarily pain associated with ejaculation).
Patients with these symptoms and identified as having prostatitis will be approached to enroll.
|
|
Controls
Male patients seen in the outpatient clinic who do not have prostatitis (not suffering from pelvic pain (perineal, suprapubic, testicular, penile etc), and do not have urinary symptoms and sexual dysfunction (primarily pain associated with ejaculation)) will be approached to enrol as controls.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expressed Prostatic Secretions (EPS) for bacterial species in prostatitis patients vs controls
Time Frame: 1 day
|
Expressed Prostatic Secretions (EPS) will be collected post Digital Rectal Exam (DRE).
These biological samples will be tested for bacterial DNA rather than the traditional microbiological culturing techniques.
Identification of these bacterial DNA will then be assessed between the groups to determine if prostatitis patients, in fact, do have more bacteria than normal controls.
|
1 day
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VB3 sample or first void after DRE for prostatitis patients vs controls
Time Frame: 1 day
|
These biological samples will be tested for bacterial DNA rather than the traditional microbiological culturing techniques.
Identification of these bacterial DNA will then be assessed between the groups to determine if prostatitis patients, in fact, do have more bacteria than normal controls.
|
1 day
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chronic Prostatitis Symptom Index (CPSI)
Time Frame: 1 day
|
Validated and standardized questionnaire for this area of research will be filled out by prostatitis patients and controls.
|
1 day
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- H13-01947
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.